S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
3 Stocks to Watch This Earnings Season
Top 3 Materials Stocks to Buy for 2021
Be Ready to Buy Broadcom (NASDAQ: AVGO) Stock at Opportunistic Pullback Levels
Here’s Where Xpeng (NASDAQ: XPEV) Stock Looks Attractive
Work on Keystone XL pipeline suspended ahead of Biden action
Global shares mostly up on optimism for stimulus from Biden
Buttigieg aims for 'generational' change at Transportation
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
3 Stocks to Watch This Earnings Season
Top 3 Materials Stocks to Buy for 2021
Be Ready to Buy Broadcom (NASDAQ: AVGO) Stock at Opportunistic Pullback Levels
Here’s Where Xpeng (NASDAQ: XPEV) Stock Looks Attractive
Work on Keystone XL pipeline suspended ahead of Biden action
Global shares mostly up on optimism for stimulus from Biden
Buttigieg aims for 'generational' change at Transportation
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
3 Stocks to Watch This Earnings Season
Top 3 Materials Stocks to Buy for 2021
Be Ready to Buy Broadcom (NASDAQ: AVGO) Stock at Opportunistic Pullback Levels
Here’s Where Xpeng (NASDAQ: XPEV) Stock Looks Attractive
Work on Keystone XL pipeline suspended ahead of Biden action
Global shares mostly up on optimism for stimulus from Biden
Buttigieg aims for 'generational' change at Transportation
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
3 Stocks to Watch This Earnings Season
Top 3 Materials Stocks to Buy for 2021
Be Ready to Buy Broadcom (NASDAQ: AVGO) Stock at Opportunistic Pullback Levels
Here’s Where Xpeng (NASDAQ: XPEV) Stock Looks Attractive
Work on Keystone XL pipeline suspended ahead of Biden action
Global shares mostly up on optimism for stimulus from Biden
Buttigieg aims for 'generational' change at Transportation
Log in
CNSX:LOVE

Cannara Biotech Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
$0.10
MA: $0.10▼
$0.11
52-Week Range N/A
Volume69,070 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cannara Biotech Inc. is a vertically integrated cannabis company building the largest indoor cannabis cultivation facility in Quebec, a modern and secure 625,000 square foot facility. Leveraging Quebec's low electricity costs, Cannara will produce high-grade indoor cannabis, specializing in derivative products and brands.

MarketRank™

Overall MarketRank™

0.68 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange CNSX
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolCNSX:LOVE
Previous Symbol
CUSIPN/A
CIKN/A
Webcannara.ca
PhoneN/A
EmployeesN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive LOVE News and Ratings via Email

Sign-up to receive the latest news and ratings for LOVE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cannara Biotech (CNSX:LOVE) Frequently Asked Questions

What stocks does MarketBeat like better than Cannara Biotech?

Wall Street analysts have given Cannara Biotech a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cannara Biotech wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Cannara Biotech's key competitors?

Some companies that are related to Cannara Biotech include (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Abacus Health Products (ABAHF), Acreage (ACRGF), Althea Group Holdings Limited (AGH.AX) (AGH), Applied Biosciences (APPB), AusCann Group Holdings Ltd (AC8.AX) (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), CannPal Animal Therapeutics Limited (CP1.AX) (CP1) and Cansortium (CNTMF).
View all of LOVE's competitors.

What other stocks do shareholders of Cannara Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cannara Biotech investors own include Aurora Cannabis (ACB), FSD Pharma (HUGE), Aurora Cannabis Inc. (ACB.TO) (ACB), (APHA), Brookfield Property Partners (BPY), Cross Timbers Royalty Trust (CRT), Emerald Health Therapeutics, Inc. (EMH.V) (EMH), HEXO Corp. (HEXO.TO) (HEXO), Harvest One Cannabis Inc. (HVT.V) (HVT) and KushCo (KSHB).

What is Cannara Biotech's stock symbol?

Cannara Biotech trades on the CNSX under the ticker symbol "LOVE."

How do I buy shares of Cannara Biotech?

Shares of LOVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cannara Biotech's official website?

The official website for Cannara Biotech is cannara.ca.

This page was last updated on 1/21/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.